Alzheimer’s & Dementia Monthly News Roundup

A monthly recap of the latest news about Alzheimer’s and dementia Study on caregivers finds brief bouts of lucidity are common among people with dementia By conducting in-depth interviews with family caregivers of people with severe dementia, researchers have documented how many of those caregivers witnessed paradoxical lucidity, an unexpected return of mental clarity in

Alzheimer’s & Dementia News Roundup (May 2024)

A monthly recap of the latest news about Alzheimer’s and dementia   Mediterranean staple may lower your risk of death from dementia, study finds A daily spoonful of olive oil could lower your risk of dying from dementia, according to a new study by Harvard scientists. Read more.   Study defines major genetic form of

Alzheimer’s & Dementia News Roundup (April 2024)

A monthly recap of the latest news about Alzheimer’s and dementia    Following the MIND diet may help slow aging and lower dementia risk, study shows New research suggests that following an eating plan called the MIND diet may slow down biological aging. Read more here.  Disruption of a molecular pathway may be involved in

April 30th, 2024|Clinical Research|

What you need to know about Lecanemab

  Learn more about the Alzheimer's drug Lecanemab (marketed as Leqembi), which just received accelerated approval from the FDA. Watch Alzheimer's Orange County CEO, Jim McAleer and CMO of Irvine Clinical Research, Dr. Trinh explain the science behind the new Alzheimer's drug and how it works. *Video recorded on December 2022 prior to the

Health Talks with Dr. Trinh feat. President & CEO, Jim McAleer

Alzheimer's Orange County Board Member, Dr. Dung Trinh and President and CEO, Jim McAleer discuss recent Alzheimer's disease breakthroughs and research updates in this entry of the "Health Talks with Dr. Trinh" series airing on OC Talk Radio. Watch the full interview below.

Agitation and Aggression Associated with Alzheimer’s Dementia: Coping Strategies for Caregivers

Brough to you by the ASPECT™ clinical research study Alzheimer’s dementia is most commonly associated with memory loss, but this form of dementia causes other significant symptoms as well. One of the most prevalent of these symptoms is agitation. If you care for someone with agitation associated with Alzheimer’s dementia, you understand the challenges involved

September 23rd, 2021|Clinical Research|

FDA Approves New Alzheimer’s Drug

July 9, 2021 Message from the CEO Earlier this week, the FDA approved the first drug for Alzheimer’s Disease in nearly 20 years. The new drug, Aducanumab, or Aduhelm, is the first Alzheimer’s treatment to attack the disease process instead of just addressing dementia symptoms. The drug is designed to reduce beta amyloid, the protein

Spending Time with Pets Provides Benefits for Older Adults

A Guest Blog from Home Instead Senior care experts say seniors who interact with animals feel less depressed and isolated. Isolation is becoming an increasingly common issue, with one in five Americans reporting they feel lonely. Seniors are especially vulnerable to these feelings. In fact, 43 percent say they experience loneliness regularly. A new survey

Alzheimer’s & Dementia Weekly Roundup (July 26, 2019)

A weekly recap of the latest news about Alzheimer’s and dementia   Alzheimer's Orange County compiles a weekly roundup of the latest news stories and developments about Alzheimer's and dementia to keep you updated on what's happening locally and all around the world. Check out this week's headlines below:   3 New Alzheimer’s Studies’ Goals:

Go to Top